QT Prolongation
1. Liu BA, Juurlink DN. Drugs and the QT interval: caveat doctor. N Engl J Med 2004;351(11):1053-6.2. Al-Khatib SM, LaPointe NM, Kramer JM, Cali RM. What clinicians should know about the QT interval. JAMA 2003;289:2120-27.3. Roden DM. Drug induced prolongation of the QT interval. N Engl J Med 2004;3...
Gespeichert in:
| Veröffentlicht in: | Canadian pharmacists journal 2016-05, Vol.149 (3), p.138-138 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | 1. Liu BA, Juurlink DN. Drugs and the QT interval: caveat doctor. N Engl J Med 2004;351(11):1053-6.2. Al-Khatib SM, LaPointe NM, Kramer JM, Cali RM. What clinicians should know about the QT interval. JAMA 2003;289:2120-27.3. Roden DM. Drug induced prolongation of the QT interval. N Engl J Med 2004;350:1013-22.4. Drew BJ, Ackerman MJ, Funk M, et al.; American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology; Council on Cardiovascular Nursing; American College of Cardiology Foundation. Prevention of torsades de pointes in hospital settings: a scientic statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010;55;934-47.5. Kannankeril P, Roden D, Darbar D. Drug-induced long QT syndrome. Pharmacol Rev 2010;62:760-81. |
|---|---|
| ISSN: | 1715-1635 1913-701X |
| DOI: | 10.1177/1715163516642209 |